BioSpectrum Asia - June 2022

I denne utgaven

Targeting Optimal DRUG DELIVERY
In recent years, several innovations have emerged around long-acting formulations and medical device development to improve patient compliance. Consequently, the growing need for controlled drug release coupled with technological advancements in pharmacology is promoting the adoption of novel drug delivery systems (NDDS). It is now crucial for Asia Pacific (APAC) drug formulators to learn and act upon these advances in therapeutic modalities that address long-standing bioavailability, dosage, and ingestion challenges of drug components to remain competitive in the global market. Simultaneously, it’s essential to optimise the therapeutic efficacy and safety profiles of a drug by regulating dosage parameters, while DDS plays an important role in administering drugs, vaccines, and therapeutic agents. Optimising these techniques enhance the performance
efficacy ratio of medications by economically managing therapeutics assets. Let’s examine recent advancements in drug delivery modalities that are greatly encouraging stakeholders’ collaboration among innovators, manufacturers, investors, and contract development and manufacturing companies CDMOs) who are capitalising on competitive advantages.

China, Brazil join hands to boost health cooperation

Ma Xiaowei, Minister of China’s National Health Commission (NHC) recently had a meeting with Marcelo Queiroga, Brazil’s Health Minister to exchange views on further deepening bilateral and multilateral health cooperation.

1 min

India Unveils Angel Investor Network For Biotech Startups

To unlock the potential of Indian the Biotechnology startups, Industry Research Assistance Council (BIRAC) has collaborated with the Indian Angel Network (IAN) to launch an angel investor network, BioAngels.

1 min

WHO validates China's Convidecia as 11th vaccine for COVID-19

The World Health Organisation (WHO) has issued an emergency use listing (EUL) for Convidecia, a vaccine manufactured by CanSino Biologics, China, adding to a growing portfolio of vaccines validated by WHO for the prevention of COVID-19 caused by SARS-CoV-2.

1 min

Targeting Optimal DRUG DELIVERY

In recent years, several innovations have emerged around long-acting formulations and medical device development to improve patient compliance. Consequently, the growing need for controlled drug release coupled with technological advancements in pharmacology is promoting the adoption of novel drug delivery systems (NDDS). It is now crucial for Asia Pacific (APAC) drug formulators to learn and act upon these advances in therapeutic modalities that address long-standing bioavailability, dosage, and ingestion challenges of drug components to remain competitive in the global market. Simultaneously, it's essential to optimise the therapeutic efficacy and safety profiles of a drug by regulating dosage parameters, while DDS plays an important role in administering drugs, vaccines, and therapeutic agents. Optimising these techniques enhance the performance efficacy ratio of medications by economically managing therapeutics assets. Let's examine recent advancements in drug delivery modalities that are greatly encouraging stakeholders' collaboration among innovators, manufacturers, investors, and contract development and manufacturing companies (CDMOs) who are capitalising on competitive advantages.

10+ mins

Ensuring Digital Health Standards

The use of digital health (DH) has grown rapidly over the last couple of years - accelerating even more during the COVID-19 pandemic. As DH becomes part of the traditional healthcare system, it's important to have stringent regulations and higher levels of scrutiny. Regulators around the world and in Asia are realising this fact and changing regulations accordingly. Let's look at the regulatory landscape in APAC.

4 mins

It is our goal to fuel R&D in the region

UK-based Abcam, a global innovator working together with life scientists to advance research and enable faster breakthroughs, has officially opened its newest regional hub in Singapore recently.

4 mins

80% Of Premature Heart Attacks And Strokes Are Preventable

Widespread chronic disease and ageing populations are necessitating a pressing change in the model of care, as there will be close to half a billion people aged 65 and older in the Asia Pacific (APAC) region by 2025.

5 mins

Our approach to managing the side effects of cancer therapy has evolved

Although there has been tremendous progress in discovering and developing new therapies to treat cancer patients, innovation in treating or preventing the side effects has lagged in comparison.

5 mins

AIM brings innovations from labs to hospitals and masses

The human body, like Space, is an endless frontier made even more complex by the irreversibility of life by the arrow of time. Similar to the mystery of origin of the Universe some problems in the human body are so complex, for example, the problem of qualia or the hard problem of consciousness– ‘Why any physical state is conscious rather than nonconscious’ that it has given the league of neuroscientists, philosophers and empiricists a perpetual “Whereof one cannot speak, thereof one must be silent” or the Upanishadic ‘Neti Neti’ limbo.

10 mins

India develops tiny robots to enhance dental care

Nano-sized robots manipulated using a magnetic field can help kill bacteria deep inside dentinal tubules, and boost the success of root canal treatments, as per a new study by researchers at the Indian Institute of Science (IISc) and IIScincubated startup, Theranautilus.

1 min

Les alle historiene fra BioSpectrum Asia

BioSpectrum Asia Magazine Description:

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.